Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan.
Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan; Department of Radiology, University of Michigan Health System, 1500 E. Medical Center Dr. B2-A209P, Ann Arbor MI, 48108.
Acad Radiol. 2019 May;26(5):585-590. doi: 10.1016/j.acra.2018.11.025.
To determine the utility of routine postbronchoscopy chest radiography to detect pneumothorax.
This retrospective quality improvement cohort study was approved by the Institutional Review Board. All outpatients (n = 1443) who underwent protocol-driven postbronchoscopy chest radiography in one health system from January 2010 to July 2017 were identified by electronic medical record query. The prevalence of pneumothorax (with 95% confidence intervals [CI]) and clinical outcome were determined following coded review of chest radiography reports and review of the electronic medical record. The effect of smoking and lung disease on risk of pneumothorax was determined with Chi Square tests.
Of 1443 subjects undergoing interventional bronchoscopy, 6% (93/1443) were current smokers, 35% (505/1442) were former smokers, and 35% (540/1443) had known lung disease. Pneumothorax prevalence was 3.4% (49/1443; 95% CI: 2.6%-4.5%) following any intervention and 4.1% (42/1032; 95% CI: 3.9%-5.5%) following transbronchial intervention. In those without known pre-existing pneumothorax or a confirmed false positive diagnosis, the real overall pneumothorax rate was 2.9% (42/1443; 95% CI: 2.1%-3.9%). The risk of pneumothorax did not differ based on smoking history (p = 0.99) or history of lung disease (p = 0.19). Of 49 subjects with pneumothorax, 13 were symptomatic, and 10 had a change in management including chest tube placement (N = 2), inpatient admission (N = 3), and/or observation (N = 7). No pneumothorax-related intervention was performed in asymptomatic patients.
Pneumothorax following interventional outpatient bronchoscopy is uncommon, usually asymptomatic, and often clinically insignificant. Asymptomatic postbronchoscopy patients are very low risk and may not need routine imaging.
确定常规支气管镜检查后胸部 X 线摄影检测气胸的效用。
本回顾性质量改进队列研究经机构审查委员会批准。通过电子病历查询,确定了 2010 年 1 月至 2017 年 7 月期间在一个医疗系统中接受常规支气管镜检查后胸部 X 线摄影的所有门诊患者(n=1443)。通过对胸部 X 线摄影报告的编码审查和电子病历的审查,确定气胸的发生率(95%置信区间[CI])和临床结局。使用卡方检验确定吸烟和肺部疾病对气胸风险的影响。
在 1443 例行介入性支气管镜检查的患者中,6%(93/1443)为现吸烟者,35%(505/1442)为前吸烟者,35%(540/1443)患有已知肺部疾病。任何干预后气胸的发生率为 3.4%(49/1443;95%CI:2.6%-4.5%),经支气管镜介入后气胸的发生率为 4.1%(42/1032;95%CI:3.9%-5.5%)。在没有已知的预先存在的气胸或已确认的假阳性诊断的情况下,真正的总体气胸发生率为 2.9%(42/1443;95%CI:2.1%-3.9%)。气胸的风险与吸烟史(p=0.99)或肺部疾病史(p=0.19)无关。在 49 例气胸患者中,13 例有症状,10 例因气胸改变了治疗方法,包括胸腔引流管放置(N=2)、住院(N=3)和/或观察(N=7)。无症状患者未进行气胸相关干预。
门诊介入性支气管镜检查后气胸并不常见,通常无症状,且往往无临床意义。无症状的支气管镜检查后患者风险非常低,可能不需要常规成像。